These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9034978)

  • 1. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 2. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 3. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 4. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What's in the future? New NSAIDs].
    Laufer S
    Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
    [No Abstract]   [Full Text] [Related]  

  • 6. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

  • 10. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
    Steinhilber D
    Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
    Warner TD; Mitchell JA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
    [No Abstract]   [Full Text] [Related]  

  • 13. No value in chronological classification of COX inhibitors.
    Bakhle YS
    Trends Pharmacol Sci; 2004 Jul; 25(7):348-9; author reply 349-50. PubMed ID: 15219973
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
    Davis P; Juby A; Robertson S; Richard N
    J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
    [No Abstract]   [Full Text] [Related]  

  • 15. Rational use of analgesic and antiinflammatory drugs.
    Crofford LJ
    N Engl J Med; 2001 Dec; 345(25):1844-6. PubMed ID: 11752364
    [No Abstract]   [Full Text] [Related]  

  • 16. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclooxygenase (COX) inhibitors: a comparative QSAR study.
    Garg R; Kurup A; Mekapati SB; Hansch C
    Chem Rev; 2003 Mar; 103(3):703-32. PubMed ID: 12630850
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
    Kankaanranta H; Vapaatalo H
    Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
    [No Abstract]   [Full Text] [Related]  

  • 20. The classification of cyclooxygenase inhibitors.
    Lipsky LP; Abramson SB; Crofford L; Dubois RN; Simon LS; van de Putte LB
    J Rheumatol; 1998 Dec; 25(12):2298-303. PubMed ID: 9858421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.